Cargando…
One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19
The immunological mechanisms that modulate immune response to SARS‐CoV‐2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID‐19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a...
Autores principales: | Alfano, Gaetano, Fontana, Francesco, Morisi, Niccolò, Giaroni, Francesco, Mori, Giacomo, Guaraldi, Giovanni, Magistroni, Riccardo, Cappelli, Gianni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597126/ https://www.ncbi.nlm.nih.gov/pubmed/34231319 http://dx.doi.org/10.1111/hdi.12963 |
Ejemplares similares
-
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021) -
SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience
por: Fontana, Francesco, et al.
Publicado: (2020) -
SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience
por: Fontana, Francesco, et al.
Publicado: (2020) -
Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis
por: Alfano, Gaetano, et al.
Publicado: (2021) -
Methicillin-Resistant Staphylococcus aureus Peritonitis due to Hematogenous Dissemination from Central Venous Catheter in a Maintenance Dialysis Patient
por: Alfano, Gaetano, et al.
Publicado: (2021)